Next Article in Journal
Unraveling Venetoclax Resistance: Navigating the Future of HMA/Venetoclax-Refractory AML in the Molecular Era
Previous Article in Journal
Correction: Turchi et al. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. Cancers 2023, 15, 5038
Previous Article in Special Issue
Effects of Opioids in Cancer Pain: An Interplay Among Genetic Factors, Immune Response, and Clinical Outcomes—A Scoping Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 17
Issue 9
10.3390/cancers17091585
Version Notes
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article

Article Versions Notes

Cancers 2025, 17(9), 1585; https://doi.org/10.3390/cancers17091585
Action Date Notes Link
article xml file uploaded 7 May 2025 08:29 CEST Original file -
article xml uploaded. 7 May 2025 08:29 CEST Update https://www.mdpi.com/2072-6694/17/9/1585/xml
article pdf uploaded. 7 May 2025 08:29 CEST Version of Record https://www.mdpi.com/2072-6694/17/9/1585/pdf
article supplementary file uploaded. 7 May 2025 08:29 CEST - https://www.mdpi.com/2072-6694/17/9/1585#supplementary
article html file updated 7 May 2025 08:33 CEST Original file https://www.mdpi.com/2072-6694/17/9/1585/html
Back to TopTop